These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 7886621)
1. In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine. Jordan S; Kramer GL; Zukas PK; Moeller M; Petty F Synapse; 1994 Dec; 18(4):294-7. PubMed ID: 7886621 [TBL] [Abstract][Full Text] [Related]
2. Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex. Ago Y; Nakamura S; Baba A; Matsuda T Neuropsychopharmacology; 2005 Jan; 30(1):43-51. PubMed ID: 15383832 [TBL] [Abstract][Full Text] [Related]
3. Effect of milnacipran on extracellular monoamine concentrations in the medial prefrontal cortex of rats pre-treated with lithium. Kitaichi Y; Inoue T; Nakagawa S; Izumi T; Koyama T Eur J Pharmacol; 2005 Jun; 516(3):219-26. PubMed ID: 15963494 [TBL] [Abstract][Full Text] [Related]
4. Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex. Rollema H; Wilson GG; Lee TC; Folgering JH; Flik G Neurochem Int; 2011 Jan; 58(1):78-84. PubMed ID: 21056607 [TBL] [Abstract][Full Text] [Related]
5. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity. Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549 [TBL] [Abstract][Full Text] [Related]
6. R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study. Koch S; Perry KW; Nelson DL; Conway RG; Threlkeld PG; Bymaster FP Neuropsychopharmacology; 2002 Dec; 27(6):949-59. PubMed ID: 12464452 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study. Beyer CE; Boikess S; Luo B; Dawson LA J Psychopharmacol; 2002 Dec; 16(4):297-304. PubMed ID: 12503828 [TBL] [Abstract][Full Text] [Related]
8. Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: a dual probe microdialysis study in awake rat. Ferraro L; Fuxe K; Agnati L; Tanganelli S; Tomasini MC; Antonelli T Synapse; 2005 Mar; 55(4):230-41. PubMed ID: 15668907 [TBL] [Abstract][Full Text] [Related]
9. Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex. Berridge CW; Stalnaker TA Synapse; 2002 Dec; 46(3):140-9. PubMed ID: 12325041 [TBL] [Abstract][Full Text] [Related]
10. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Bymaster FP; Zhang W; Carter PA; Shaw J; Chernet E; Phebus L; Wong DT; Perry KW Psychopharmacology (Berl); 2002 Apr; 160(4):353-61. PubMed ID: 11919662 [TBL] [Abstract][Full Text] [Related]
11. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice. Koda K; Ago Y; Cong Y; Kita Y; Takuma K; Matsuda T J Neurochem; 2010 Jul; 114(1):259-70. PubMed ID: 20403082 [TBL] [Abstract][Full Text] [Related]
13. Effect of corticotropin releasing factor receptor 1 antagonist on extracellular norepinephrine, dopamine and serotonin in hippocampus and prefrontal cortex of rats in vivo. Isogawa K; Akiyoshi J; Hikichi T; Yamamoto Y; Tsutsumi T; Nagayama H Neuropeptides; 2000; 34(3-4):234-9. PubMed ID: 11021986 [TBL] [Abstract][Full Text] [Related]
14. Central administration of NPY or an NPY-Y5 selective agonist increase in vivo extracellular monoamine levels in mesocorticolimbic projecting areas. Quarta D; Leslie CP; Carletti R; Valerio E; Caberlotto L Neuropharmacology; 2011; 60(2-3):328-35. PubMed ID: 20868698 [TBL] [Abstract][Full Text] [Related]
15. The effects of acetaldehyde on nicotine-induced transmitter levels in young and adult brain areas. Sershen H; Shearman E; Fallon S; Chakraborty G; Smiley J; Lajtha A Brain Res Bull; 2009 Aug; 79(6):458-62. PubMed ID: 19389462 [TBL] [Abstract][Full Text] [Related]
16. In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies. Bel N; Artigas F J Pharmacol Exp Ther; 1996 Sep; 278(3):1064-72. PubMed ID: 8819487 [TBL] [Abstract][Full Text] [Related]
17. Chronic antidepressant treatment alters serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons. Zhong P; Yan Z Neuroscience; 2004; 129(1):65-73. PubMed ID: 15489029 [TBL] [Abstract][Full Text] [Related]
18. Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex. Page ME; Lucki I Neuropsychopharmacology; 2002 Aug; 27(2):237-47. PubMed ID: 12093597 [TBL] [Abstract][Full Text] [Related]
19. Adaptation of monoaminergic responses to phencyclidine in nucleus accumbens and prefrontal cortex following repeated treatment with fluoxetine or imipramine. De La Garza R; Jentsch JD; Verrico CD; Roth RH Brain Res; 2002 Dec; 958(1):20-7. PubMed ID: 12468026 [TBL] [Abstract][Full Text] [Related]
20. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats. Mochizuki D; Tsujita R; Yamada S; Kawasaki K; Otsuka Y; Hashimoto S; Hattori T; Kitamura Y; Miki N Psychopharmacology (Berl); 2002 Jul; 162(3):323-32. PubMed ID: 12122491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]